878 related articles for article (PubMed ID: 26891932)
1. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
Sharma R; Mody N; Agrawal U; Vyas SP
Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium theranostics for the diagnosis and treatment of cancer.
Robertson AG; Rendina LM
Chem Soc Rev; 2021 Apr; 50(7):4231-4244. PubMed ID: 33599224
[TBL] [Abstract][Full Text] [Related]
3. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
Kundu P; Singh D; Singh A; Sahoo SK
Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
[TBL] [Abstract][Full Text] [Related]
4. Theranostic Potential of Targeted Nanoparticles for Brain Cancer.
Bhatt A; Gurnany E; Modi A; Gulbake A; Jain A
Mini Rev Med Chem; 2017; 17(18):1758-1777. PubMed ID: 28969541
[TBL] [Abstract][Full Text] [Related]
5. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
6. Metal nanoparticles: a theranostic nanotool against cancer.
Sharma H; Mishra PK; Talegaonkar S; Vaidya B
Drug Discov Today; 2015 Sep; 20(9):1143-51. PubMed ID: 26007605
[TBL] [Abstract][Full Text] [Related]
7. Glycol chitosan-based fluorescent theranostic nanoagents for cancer therapy.
Rhee JK; Park OK; Lee A; Yang DH; Park K
Mar Drugs; 2014 Dec; 12(12):6038-57. PubMed ID: 25522316
[TBL] [Abstract][Full Text] [Related]
8. Theranostic applications of nanoparticles in cancer.
Ahmed N; Fessi H; Elaissari A
Drug Discov Today; 2012 Sep; 17(17-18):928-34. PubMed ID: 22484464
[TBL] [Abstract][Full Text] [Related]
9. Voyage of theranostic liposomes for imaging and therapy.
Sachin M; Sachin D; Dinesh S
J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
[TBL] [Abstract][Full Text] [Related]
10. Theranostic lipid nanoparticles for cancer medicine.
Charron DM; Chen J; Zheng G
Cancer Treat Res; 2015; 166():103-27. PubMed ID: 25895866
[TBL] [Abstract][Full Text] [Related]
11. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
Mohammadi M; Ramezani M; Abnous K; Alibolandi M
Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
[TBL] [Abstract][Full Text] [Related]
12. Cancer nanotheranostics: Strategies, promises and impediments.
Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
[TBL] [Abstract][Full Text] [Related]
13. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
[TBL] [Abstract][Full Text] [Related]
14. Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
Kumar R; Shin WS; Sunwoo K; Kim WY; Koo S; Bhuniya S; Kim JS
Chem Soc Rev; 2015 Oct; 44(19):6670-83. PubMed ID: 26118960
[TBL] [Abstract][Full Text] [Related]
15. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
Cai Y; Chen X; Si J; Mou X; Dong X
Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
[TBL] [Abstract][Full Text] [Related]
16. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
Nguyen KT; Zhao Y
Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
[TBL] [Abstract][Full Text] [Related]
17. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
18. A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?
Dreifuss T; Betzer O; Shilo M; Popovtzer A; Motiei M; Popovtzer R
Nanoscale; 2015 Oct; 7(37):15175-84. PubMed ID: 26313344
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
20. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]